Journal Editorial Report: The week’s best and worst from Allysia Finley, Jason Riley and Kim Strassel. Photo: Jeffrey T. Barnes//Mark Stockwell/Associated Press Artificial intelligence could lead to ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

A divided Food and Drug Administration panel narrowly backed a controversial blood-based cancer test Wednesday, a step forward for an emerging field of cancer screenings that could offer less invasive ...

A controversial blood test aimed at detecting multiple cancers was backed by a U.S. Food and Drug Administration panel this week. On Wednesday, Sept. 23, the FDA's Molecular and Clinical Genetics ...

Editor's note: This article was updated after the U.S. Food and Drug Administration approved the Galleri cancer test kit. When the Galleri test hit the market in 2021, it sounded enticing — it ...

Grail Inc.GRAL-0.46%decrease; down pointing triangle received a favorable vote from a Food and Drug Administration panel regarding premarket approval for its Galleri multi-cancer early detection test.

When you are trying to lose weight, just adding more protein to your diet isn't enough. The number of calories and amount of fat in that protein source also matter, especially if you are eating it ...

A key advisory committee that reviews medical devices for the Food and Drug Administration recommended the agency approve the first multi-cancer blood test for people 50 and over. Grail, the company ...

A U.S. Food and Drug Administration advisory panel voted in favor of recommending that the agency approve a blood test for multiple cancers on Wednesday. The assay, called the Galleri test, is ...

Sept 21 (Reuters) - The US FDA's staff reviewers did not raise major concerns about the accuracy and safety of Grail's (GRAL.O), opens new tab blood test designed to detect more than 50 cancers, ...